Home LiteratureArticle Details
PMID: 8198989 Published · ppublish English Editorial Review

Statistical aspects of prognostic factor studies in oncology.

British journal of cancer ·Vol. 69 ·No. 6 ·1994-06-00 ·Pages 979-85

Simon R, Altman DG

Abstract

暂无摘要

MeSH Terms
Humans Neoplasms/mortality,therapy Prognosis Proportional Hazards Models Regression Analysis Research Design Statistics as Topic/methods
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Simon R
Altman D G
References (33)
33 references, click to expand
  1. Identification and assessment of prognostic factors.
    Semin Oncol. 1988 Oct;15(5):462-71 PMID: 3051402
  2. Flexible regression models with cubic splines.
    Stat Med. 1989 May;8(5):551-61 PMID: 2657958
  3. Confidence intervals for reporting results of clinical trials.
    Ann Intern Med. 1986 Sep;105(3):429-35 PMID: 3740683
  4. Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring.
    Br J Cancer. 1993 May;67(5):1136-41 PMID: 8494713
  5. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.
    J Natl Cancer Inst. 1988 Mar 2;80(1):21-9 PMID: 3276900
  6. Bootstrap investigation of the stability of a Cox regression model.
    Stat Med. 1989 Jul;8(7):771-83 PMID: 2672226
  7. Breast cancer prognostic factors: evaluation guidelines.
    J Natl Cancer Inst. 1991 Feb 6;83(3):154-5 PMID: 1988696
  8. Evaluating serial cancer marker studies in patients at risk of recurrent disease.
    Biometrics. 1981 Mar;37(1):67-78 PMID: 7248444
  9. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients.
    J Natl Cancer Inst. 1993 Aug 4;85(15):1206-19 PMID: 8331681
  10. Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.
    Br J Cancer. 1993 Jul;68(1):195-200 PMID: 8318413
  11. The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer.
    Int J Gynecol Cancer. 1993 Sep;3(5):285-292 PMID: 11578359
  12. Patient subsets and variation in therapeutic efficacy.
    Br J Clin Pharmacol. 1982 Oct;14(4):473-82 PMID: 7138732
  13. Head and neck sarcomas: prognostic factors and implications for treatment.
    Br J Cancer. 1993 Jul;68(1):201-7 PMID: 8318414
  14. When is a prognostic factor useful? A guide for the perplexed.
    J Clin Oncol. 1991 Feb;9(2):348-56 PMID: 1988581
  15. Regression models for prognostic prediction: advantages, problems, and suggested solutions.
    Cancer Treat Rep. 1985 Oct;69(10):1071-77 PMID: 4042087
  16. Bayesian subset analysis in a colorectal cancer clinical trial.
    Stat Med. 1992 Jan 15;11(1):13-22 PMID: 1557569
  17. A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia.
    Br J Cancer. 1980 Dec;42(6):841-9 PMID: 6936051
  18. Causality inference in observational vs. experimental studies. An empirical comparison.
    Am J Epidemiol. 1988 May;127(5):885-92 PMID: 3282432
  19. Categorising continuous variables.
    Br J Cancer. 1991 Nov;64(5):975 PMID: 1931629
  20. The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
    Br J Cancer. 1985 Jul;52(1):1-6 PMID: 3893505
  21. Adjusting survival curves for imbalances in prognostic factors.
    Br J Cancer. 1988 Aug;58(2):202-4 PMID: 3166911
  22. Measures of explained variation for survival data.
    Stat Med. 1990 May;9(5):487-503 PMID: 2349402
  23. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.
    N Engl J Med. 1978 Jun 1;298(22):1223-8 PMID: 651963
  24. Testing for qualitative interactions between treatment effects and patient subsets.
    Biometrics. 1985 Jun;41(2):361-72 PMID: 4027319
  25. A proposal for examining and reporting stepwise regressions.
    Stat Med. 1991 May;10(5):711-5 PMID: 2068423
  26. Some thoughts on clinical trials, especially problems of multiplicity.
    Science. 1977 Nov 18;198(4318):679-84 PMID: 333584
  27. Flexible covariate effects in the proportional hazards model.
    Breast Cancer Res Treat. 1992;22(3):241-50 PMID: 1391990
  28. An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research.
    Br J Cancer. 1990 Apr;61(4):597-604 PMID: 2158808
  29. Analysis of clinical trial outcomes: some comments on subgroup analyses.
    Control Clin Trials. 1989 Dec;10(4 Suppl):187S-194S PMID: 2605967
  30. Why do so many prognostic factors fail to pan out?
    Breast Cancer Res Treat. 1992;22(3):197-206 PMID: 1391986
  31. Comparison of the Cox model and the regression tree procedure in analysing a randomized clinical trial.
    Stat Med. 1993 Dec 30;12(24):2351-66 PMID: 8134738
  32. Is DNA flow cytometry a useful investigation in breast cancer?
    Eur J Cancer. 1992;28(2-3):504-7 PMID: 1591074
  33. Prognostic value of continuous variables in breast cancer and head and neck cancer. Dependence on the cut-off level.
    Br J Cancer. 1988 Jul;58(1):88-90 PMID: 3166897
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
Published
1994-06-00
Pages
979-85
Language
English
Region
England
NLM ID
0370635
PMCID
PMC1969431
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]